Conservation of Copy Number Profiles During Engraftment and Passaging of Patient-derived Cancer Xenografts

Patient-derived xenografts (PDXs) are resected human tumors engrafted into mice for preclinical studies and therapeutic testing. It has been proposed that the mouse host affects tumor evolution during PDX engraftment and propagation, affecting the accuracy of PDX modeling of human cancer. Here, we exhaustively analyze copy number alterations (CNAs) in 1,451 PDX and matched patient tumor (PT) samples from 509 PDX models. CNA inferences based on DNA sequencing and microarray data displayed substantially higher resolution and dynamic range than gene expression-based inferences, and they also showed strong CNA conservation from PTs through late-passage PDXs. CNA recurrence analysis of 130 colorectal and breast PT/PDX-early/PDX-late trios confirmed high-resolution CNA retention. We observed no significant enrichment of cancer-related genes in PDX-specific CNAs across models. Moreover, CNA differences between patient and PDX tumors were comparable to variations in multiregion samples within patients. Our study demonstrates the lack of systematic copy number evolution driven by the PDX mouse host.

Citing Articles

Molecular probes for in vivo optical imaging of immune cells.

Liu J, Cheng P, Xu C, Pu K Nat Biomed Eng. 2025; .

PMID: 39984703 DOI: 10.1038/s41551-024-01275-7.

Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment.

Berezovsky A, Nuga O, Datta I, Bergman K, Sabedot T, Gurdziel K PLoS One. 2025; 20(2):e0315171.

PMID: 39919036 PMC: 11805374. DOI: 10.1371/journal.pone.0315171.

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts.

Caumanns J, Li S, Meersma G, Duiker E, van der Zee A, Wisman G Sci Rep. 2025; 15(1):4434.

PMID: 39910133 PMC: 11799314. DOI: 10.1038/s41598-025-86384-2.

Steroid hormone receptors, exome sequencing and treatment responsiveness of breast cancer patient-derived xenografts originated in a South American country.

Pataccini G, Elia A, Sequeira G, Ambrosio L, Coianis M, Lamb C Sci Rep. 2025; 15(1):2415.

PMID: 39827242 PMC: 11742900. DOI: 10.1038/s41598-025-86389-x.

Patient-Derived Xenografts of Breast Cancer.

Marangoni E Adv Exp Med Biol. 2025; 1464():109-121.

PMID: 39821023 DOI: 10.1007/978-3-031-70875-6_7.

References

Walrath J, Hawes J, Van Dyke T, Reilly K . Genetically engineered mouse models in cancer research. Adv Cancer Res. 2010; 106:113-64. PMC: 3533445. DOI: 10.1016/S0065-230X(10)06004-5. View

Hait W . Anticancer drug development: the grand challenges. Nat Rev Drug Discov. 2010; 9(4):253-4. DOI: 10.1038/nrd3144. View

Shultz L, Ishikawa F, Greiner D . Humanized mice in translational biomedical research. Nat Rev Immunol. 2007; 7(2):118-30. DOI: 10.1038/nri2017. View

Brehm M, Shultz L, Greiner D . Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes. 2010; 17(2):120-5. PMC: 2892284. DOI: 10.1097/MED.0b013e328337282f. View

Hidalgo M, Amant F, Biankin A, Budinska E, Byrne A, Caldas C . Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014; 4(9):998-1013. PMC: 4167608. DOI: 10.1158/2159-8290.CD-14-0001. View

Byrne A, Alferez D, Amant F, Annibali D, Arribas J, Biankin A . Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat Rev Cancer. 2017; 17(4):254-268. DOI: 10.1038/nrc.2016.140. View

Bruna A, Rueda O, Greenwood W, Batra A, Callari M, Batra R . A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds. Cell. 2016; 167(1):260-274.e22. PMC: 5037319. DOI: 10.1016/j.cell.2016.08.041. View

Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F . Molecular profiling of patient-derived breast cancer xenografts. Breast Cancer Res. 2012; 14(1):R11. PMC: 3496128. DOI: 10.1186/bcr3095. View

Landis M, Lehmann B, Pietenpol J, Chang J . Patient-derived breast tumor xenografts facilitating personalized cancer therapy. Breast Cancer Res. 2013; 15(1):201. PMC: 3672825. DOI: 10.1186/bcr3355. View

10.

Derose Y, Wang G, Lin Y, Bernard P, Buys S, Ebbert M . Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med. 2011; 17(11):1514-20. PMC: 3553601. DOI: 10.1038/nm.2454. View

11.

Bankert R, Balu-Iyer S, Odunsi K, Shultz L, Kelleher Jr R, Barnas J . Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis. PLoS One. 2011; 6(9):e24420. PMC: 3174163. DOI: 10.1371/journal.pone.0024420. View

12.

Julien S, Merino-Trigo A, Lacroix L, Pocard M, Goere D, Mariani P . Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer. Clin Cancer Res. 2012; 18(19):5314-28. DOI: 10.1158/1078-0432.CCR-12-0372. View

13.

Lee H, Lee J, Lee S, Cho H, Song H, Jeong D . Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy. Clin Cancer Res. 2015; 21(5):1172-82. DOI: 10.1158/1078-0432.CCR-14-1589. View

14.

Gao H, Korn J, Ferretti S, Monahan J, Wang Y, Singh M . High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat Med. 2015; 21(11):1318-25. DOI: 10.1038/nm.3954. View

15.

Hidalgo M, Bruckheimer E, Rajeshkumar N, Garrido-Laguna I, de Oliveira E, Rubio-Viqueira B . A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer. Mol Cancer Ther. 2011; 10(8):1311-6. PMC: 4629061. DOI: 10.1158/1535-7163.MCT-11-0233. View

16.

Tentler J, Tan A, Weekes C, Jimeno A, Leong S, Pitts T . Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol. 2012; 9(6):338-50. PMC: 3928688. DOI: 10.1038/nrclinonc.2012.61. View

17.

Eirew P, Steif A, Khattra J, Ha G, Yap D, Farahani H . Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature. 2014; 518(7539):422-6. PMC: 4864027. DOI: 10.1038/nature13952. View

18.

Cho S, Chae J, Na D, Kang W, Lee A, Min S . Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers. Clin Cancer Res. 2019; 25(9):2821-2834. PMC: 7875093. DOI: 10.1158/1078-0432.CCR-18-3460. View

19.

Ding L, Ellis M, Li S, Larson D, Chen K, Wallis J . Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature. 2010; 464(7291):999-1005. PMC: 2872544. DOI: 10.1038/nature08989. View

20.

Giessler K, Kleinheinz K, Huebschmann D, Balasubramanian G, Dubash T, Dieter S . Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer. J Exp Med. 2017; 214(7):2073-2088. PMC: 5502434. DOI: 10.1084/jem.20162017. View